1. Home
  2. HOFT vs GNLX Comparison

HOFT vs GNLX Comparison

Compare HOFT & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hooker Furnishings Corporation

HOFT

Hooker Furnishings Corporation

HOLD

Current Price

$16.80

Market Cap

144.6M

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$3.00

Market Cap

133.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOFT
GNLX
Founded
1924
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.6M
133.0M
IPO Year
1999
2022

Fundamental Metrics

Financial Performance
Metric
HOFT
GNLX
Price
$16.80
$3.00
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$17.25
AVG Volume (30 Days)
101.7K
189.2K
Earning Date
04-16-2026
05-12-2026
Dividend Yield
3.79%
N/A
EPS Growth
N/A
9.47
EPS
0.10
N/A
Revenue
$278,139,000.00
$8,000.00
Revenue This Year
$17.37
N/A
Revenue Next Year
$9.00
N/A
P/E Ratio
$176.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.62
$2.29
52 Week High
$18.09
$8.54

Technical Indicators

Market Signals
Indicator
HOFT
GNLX
Relative Strength Index (RSI) 61.72 54.39
Support Level $11.99 $2.36
Resistance Level $17.65 $3.03
Average True Range (ATR) 1.06 0.18
MACD 0.10 0.00
Stochastic Oscillator 59.38 76.98

Price Performance

Historical Comparison
HOFT
GNLX

About HOFT Hooker Furnishings Corporation

Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: